Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17011449rdf:typepubmed:Citationlld:pubmed
pubmed-article:17011449lifeskim:mentionsumls-concept:C0006826lld:lifeskim
pubmed-article:17011449lifeskim:mentionsumls-concept:C0008838lld:lifeskim
pubmed-article:17011449lifeskim:mentionsumls-concept:C1517927lld:lifeskim
pubmed-article:17011449lifeskim:mentionsumls-concept:C0045093lld:lifeskim
pubmed-article:17011449lifeskim:mentionsumls-concept:C0086960lld:lifeskim
pubmed-article:17011449lifeskim:mentionsumls-concept:C0205179lld:lifeskim
pubmed-article:17011449lifeskim:mentionsumls-concept:C0521115lld:lifeskim
pubmed-article:17011449lifeskim:mentionsumls-concept:C2728259lld:lifeskim
pubmed-article:17011449pubmed:issue3lld:pubmed
pubmed-article:17011449pubmed:dateCreated2006-10-2lld:pubmed
pubmed-article:17011449pubmed:abstractTextAdministration of gemcitabine together with cisplatin at cytotoxic doses in a chemoradiotherapy regimen is hampered by a high degree of local toxicity. Using the pharmacologic properties of the drug we designed a modified schedule aimed at reducing toxicity while preserving activity.lld:pubmed
pubmed-article:17011449pubmed:languageenglld:pubmed
pubmed-article:17011449pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17011449pubmed:citationSubsetIMlld:pubmed
pubmed-article:17011449pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17011449pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17011449pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17011449pubmed:statusMEDLINElld:pubmed
pubmed-article:17011449pubmed:monthNovlld:pubmed
pubmed-article:17011449pubmed:issn0360-3016lld:pubmed
pubmed-article:17011449pubmed:authorpubmed-author:NumicoGianmau...lld:pubmed
pubmed-article:17011449pubmed:authorpubmed-author:GranettoCrist...lld:pubmed
pubmed-article:17011449pubmed:authorpubmed-author:GarroneOrnell...lld:pubmed
pubmed-article:17011449pubmed:authorpubmed-author:GascoMilenaMlld:pubmed
pubmed-article:17011449pubmed:authorpubmed-author:MerlanoMarcoMlld:pubmed
pubmed-article:17011449pubmed:authorpubmed-author:RussiElvio...lld:pubmed
pubmed-article:17011449pubmed:authorpubmed-author:FeaElenaElld:pubmed
pubmed-article:17011449pubmed:authorpubmed-author:OccelliMarcel...lld:pubmed
pubmed-article:17011449pubmed:authorpubmed-author:Di...lld:pubmed
pubmed-article:17011449pubmed:authorpubmed-author:ColantonioIda...lld:pubmed
pubmed-article:17011449pubmed:authorpubmed-author:TagliantiRicc...lld:pubmed
pubmed-article:17011449pubmed:authorpubmed-author:PelisseroAnto...lld:pubmed
pubmed-article:17011449pubmed:authorpubmed-author:CipolatMarcoMlld:pubmed
pubmed-article:17011449pubmed:authorpubmed-author:VitielloRaffe...lld:pubmed
pubmed-article:17011449pubmed:authorpubmed-author:SorrentinoRaf...lld:pubmed
pubmed-article:17011449pubmed:issnTypePrintlld:pubmed
pubmed-article:17011449pubmed:day1lld:pubmed
pubmed-article:17011449pubmed:volume66lld:pubmed
pubmed-article:17011449pubmed:ownerNLMlld:pubmed
pubmed-article:17011449pubmed:authorsCompleteYlld:pubmed
pubmed-article:17011449pubmed:pagination731-7lld:pubmed
pubmed-article:17011449pubmed:meshHeadingpubmed-meshheading:17011449...lld:pubmed
pubmed-article:17011449pubmed:meshHeadingpubmed-meshheading:17011449...lld:pubmed
pubmed-article:17011449pubmed:meshHeadingpubmed-meshheading:17011449...lld:pubmed
pubmed-article:17011449pubmed:meshHeadingpubmed-meshheading:17011449...lld:pubmed
pubmed-article:17011449pubmed:meshHeadingpubmed-meshheading:17011449...lld:pubmed
pubmed-article:17011449pubmed:meshHeadingpubmed-meshheading:17011449...lld:pubmed
pubmed-article:17011449pubmed:meshHeadingpubmed-meshheading:17011449...lld:pubmed
pubmed-article:17011449pubmed:meshHeadingpubmed-meshheading:17011449...lld:pubmed
pubmed-article:17011449pubmed:meshHeadingpubmed-meshheading:17011449...lld:pubmed
pubmed-article:17011449pubmed:meshHeadingpubmed-meshheading:17011449...lld:pubmed
pubmed-article:17011449pubmed:meshHeadingpubmed-meshheading:17011449...lld:pubmed
pubmed-article:17011449pubmed:meshHeadingpubmed-meshheading:17011449...lld:pubmed
pubmed-article:17011449pubmed:meshHeadingpubmed-meshheading:17011449...lld:pubmed
pubmed-article:17011449pubmed:meshHeadingpubmed-meshheading:17011449...lld:pubmed
pubmed-article:17011449pubmed:meshHeadingpubmed-meshheading:17011449...lld:pubmed
pubmed-article:17011449pubmed:meshHeadingpubmed-meshheading:17011449...lld:pubmed
pubmed-article:17011449pubmed:meshHeadingpubmed-meshheading:17011449...lld:pubmed
pubmed-article:17011449pubmed:meshHeadingpubmed-meshheading:17011449...lld:pubmed
pubmed-article:17011449pubmed:meshHeadingpubmed-meshheading:17011449...lld:pubmed
pubmed-article:17011449pubmed:meshHeadingpubmed-meshheading:17011449...lld:pubmed
pubmed-article:17011449pubmed:year2006lld:pubmed
pubmed-article:17011449pubmed:articleTitleGemcitabine and cisplatin in a concomitant alternating chemoradiotherapy program for locally advanced head-and-neck cancer: a pharmacology-guided schedule.lld:pubmed
pubmed-article:17011449pubmed:affiliationMedical Oncology, S. Croce General Hospital, Cuneo, Italy. gianmauro.numico@fastwebnet.itlld:pubmed
pubmed-article:17011449pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17011449lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17011449lld:pubmed